Compare LAD & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAD | RVMD |
|---|---|---|
| Founded | 1946 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 7.5B |
| IPO Year | 1996 | 2020 |
| Metric | LAD | RVMD |
|---|---|---|
| Price | $343.25 | $77.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 18 |
| Target Price | ★ $384.83 | $77.11 |
| AVG Volume (30 Days) | 305.1K | ★ 2.2M |
| Earning Date | 10-22-2025 | 11-05-2025 |
| Dividend Yield | ★ 0.64% | N/A |
| EPS Growth | ★ 18.36 | N/A |
| EPS | ★ 34.59 | N/A |
| Revenue | ★ $37,610,600,000.00 | N/A |
| Revenue This Year | $5.64 | N/A |
| Revenue Next Year | $4.41 | $714.50 |
| P/E Ratio | $9.95 | ★ N/A |
| Revenue Growth | ★ 8.42 | N/A |
| 52 Week Low | $262.10 | $29.17 |
| 52 Week High | $405.14 | $81.49 |
| Indicator | LAD | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 62.22 | 65.66 |
| Support Level | $340.15 | $77.54 |
| Resistance Level | $360.56 | $80.44 |
| Average True Range (ATR) | 9.67 | 2.56 |
| MACD | 2.86 | -0.70 |
| Stochastic Oscillator | 65.07 | 51.02 |
Lithia Motors is a retailer of new and used vehicles and related services. The company offers over 50 brands of vehicles at nearly 500 stores globally across the US, Canada, and UK. The company has expanded largely through the acquisition of dealerships in smaller regional markets but now seeks to grow in any part of the US and we expect more deals over time in the US and, at times, abroad. Annual revenue in 2024 was $36.2 billion and we see over $50 billion possible in a few years. The US was 78% of 2024 revenue and the UK second at 19%, due to the 2024 Pendragon acquisition. In 2024, new vehicle sales were about 49% of total revenue. Lithia was founded in 1946, went public in 1996, and is the largest US auto dealer. It is based in Medford, Oregon.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.